Table 4.
Patient | Increase of IFN-γ secreting T-lymphocytes | HAMA (ng/ml) | Chemotherapy after trAb therapy | Survival after trAb therapy (months) |
A | + | 801 | - | 1 |
B | + | 230 | + | 21 |
C | - | 30512 | + | 31 |
D | - | n.d. | - | 4 |
E | + | 7870 | + | 7 |
F | - | 50730 | + | 12 |
G | + | 2540 | + | 15 |
H | - | 400 | + | 8 |
I | + | n.d. | - | 7 |
Increase of IFN-γ secreting T-lymphocytes compared to baseline values before therapy. HAMA = human anti-mouse antibody reaction (values measured 4 weeks after trAb therapy).